Gianluca Vita
Messina, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Cerebrospinal fluid biomarkers of efficacy in patients affected by spinal muscular atrophy type 1 treated with nusinersen.
Journal: Acta neurologica Belgica
Published: September 24, 2024
Opportunities for an early recognition of spinal muscular atrophy in primary care: a nationwide, population-based, study in Italy.
Journal: Family practice
Published: August 11, 2022
Genetic modifiers of upper limb function in Duchenne muscular dystrophy.
Journal: Journal of neurology
Published: March 13, 2022
Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy.
Journal: PloS one
Published: February 02, 2022
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up.
Journal: PloS one
Published: April 19, 2021
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy.
Journal: Neuromuscular disorders : NMD
Published: November 12, 2020
Type I SMA "new natural history": long-term data in nusinersen-treated patients.
Journal: Annals of clinical and translational neurology
Published: October 13, 2020
Respiratory function and therapeutic expectations in DMD: families experience and perspective.
Journal: Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
Published: September 01, 2020
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors.
Journal: Cancer treatment and research communications
Published: May 29, 2020
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury.
Journal: Molecular biology reports
Published: January 31, 2020
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study.
Journal: Frontiers in genetics
Published: September 13, 2019
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.
Journal: PloS one
Published: August 01, 2019
Last Updated: 09/26/2026